All Cardiovascular articles
-
ChecklistCommunity Pharmacist Counselling Checklist for patients with NVAF initiated on Xarelto▼ (rivaroxaban)
Information intended for healthcare professionals. This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines for Pharmacy . Please see the bottom of the page for full disclaimer. View Xarelto (rivaroxaban) prescribing information and adverse event reporting information ...
-
Independent professional body guideline
AWMSG Advice on oral anticoagulation for non-valvular atrial fibrillation
Recommendations for primary care on the role of oral anticoagulant treatment in people with non-valvular atrial fibrillation.
-
Independent professional body guideline
BSR giant cell arteritis guideline
This summary outlines the general principles of identifying and treating patients with giant cell arteritis in primary care and specialist settings. It is recommended that general practitioners refer patients with suspected giant cell arteritis to a clinician with appropriate specialist expertise.
-
Checklist
Xarelto▼ (rivaroxaban) patient counselling checklist for HCPs—initiating, or transitioning to rivaroxaban for eligible patients with DVT or PE*
Information intended for healthcare professionals. This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines . Please see the bottom of the page for full disclaimer. View Xarelto (rivaroxaban) prescribing information and adverse event reporting information Download ...
-
NICE guideline
NICE stable angina guideline
A brief summary of NICE's clinical guideline on the management of stable angina. Includes care pathway algorithm, counselling, and secondary prevention.
-
Checklist
Community Pharmacist Counselling Checklist for patients with NVAF initiated on Xarelto▼ (rivaroxaban)
Information intended for healthcare professionals. This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines for Pharmacy . Please see the bottom of the page for full disclaimer. View Xarelto (rivaroxaban) prescribing information and adverse event reporting information ...
-
Checklist
Xarelto▼ (rivaroxaban) patient counselling checklist for HCPs—initiating, or transitioning to rivaroxaban for stroke prevention in patients with NVAF*
Information intended for healthcare professionals. This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines . Please see the bottom of the page for full disclaimer. View Xarelto (rivaroxaban) prescribing information and adverse event reporting information Download ...
-
Working party guideline/algorithm
Consensus guideline on the holistic management of patients requiring anticoagulation
This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of a grant from Bayer plc.
-
NICE guideline
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
This useful summary covers diagnosis and initial management, outpatient treatment for low-risk pulmonary embolism, anticoagulation treatment for suspected or confirmed deep vein thrombosis or pulmonary embolism, and information and support for people having anticoagulation treatment
-
Video
Professor Terry McCormack Q&A on hypertension
In this video, taken at Guidelines Live 2019, Professor Terry McCormack answers questions on hypertension guidelines, recommendations in these guidelines, red flags for referral, and his key take-home messages.
-
Video
Dr Jim Moore Q&A on ABC cardiovascular plan
In this video, taken at Guidelines Live 2019, Dr Jim Moore answers questions on identifying and treating atrial fibrillation, high blood pressure, and raised cholesterol, guidance to help manage patients at risk of heart disease, and his key take-home messages.
-
NICE guideline
NICE abdominal aortic aneurysm guideline
This Guidelines summary covers diagnosis, monitoring and reducing the risk of rupture, and emergency transfer to regional vascular services
-
Information
ClinOwl: a new resource for healthcare professionals
ClinOwl is a new content discovery platform for healthcare professionals, delivering the latest clinical articles from the leading medical journals in a single view Browse and search over 18,000 articles organised across 40+ clinical specialties and sub-specialties. You can also sign up to ...
-
NICE guideline
NICE FH guideline
Summary of NICE guidance on the identification and management of familial hypercholesterolaemia, which includes diagnostic criteria and when to refer.
-
Guidance card
NICE Technology Appraisal 607: Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease
The production of this Guidelines card has been commissioned by Bayer plc. Bayer plc has reviewed the card for technical accuracy and regulatory compliance and supplied the prescribing information.
-
NICE guideline
NICE hypertension guideline
A brief guide on the diagnosis and management of hypertension, includes visual summaries on treatment and choice of antihypertensive drug.
-
NICE guideline
NICE stroke and TIA guideline
This concise summary covers the rapid recognition of symptoms and diagnosis of stroke and transient ischaemic attack.
-
NICE guideline
NICE hypertension in pregnancy guideline
This summary covers the diagnosis and management of hypertension during pregnancy, labour, and birth.
-
SIGN guideline
SIGN cardiac arrhythmias guideline
Read the latest recommendations on the management of atrial fibrillation and ventricular arrhythmias in acute coronary syndrome, coronary heart disease, and left-ventricular dysfunction as well as arrhythmias associated with cardiac arrest and coronary artery bypass graft.
-
Sponsored algorithm
Non-vitamin K oral anticoagulant options for patients with non-valvular atrial fibrillation and renal impairment
This NOAC dosing guide has been commissioned by Bayer, who also provided funding for its development. Bayer reviewed and approved the scope and pre-meeting documents, suggested the Chair and experts for the group, and put the dosing guide through full medical approval to ensure its compliance with appropriate regulations.
